New York · Ranked 132 of 1033 by CEO pay.
University of Rochester
David Linehan MD, SVP, Dean Smd, CEO Urmc. Fiscal year ending 2025-06.
Form 990 Part VII, columns D+E+F
Schedule H Part I line 7a
Also listed with a chief executive title in the same filings: Sarah C Mangelsdorf, Trustee, Pres & CEO, $1,803,590; Kathleen Parrinello, Pres/CEO Smh & Hh,Srvp Urmc, $1,464,961; Michael F Rotondo MD, CEO Urmfg, Sr VP Urmc, $1,436,618. Where a chief executive retired during the year, the filing reports the final-year payout.
§1The filing
- Total revenue
- $6,415,541,241
- Total expenses
- $6,345,806,430
- Net assets
- $5,179,884,502
- Employees
- 37,371
- Hospitals covered
- 1 facilities across 1 filing
- Charity care, net
- $34,829,180
- Bad debt
- $25,547,323
- Medicare surplus (shortfall), as filed
- ($68,621,242)
- CEO pay from the organization (Part VII col. D)
- $2,268,785
- From related organizations (col. E)
- $0
- Other compensation, including deferred pay and nontaxable benefits (col. F)
- $221,433
- CEO total compensation (D+E+F)
- $2,490,218 to David Linehan MD
Medicare surplus (shortfall) is Schedule H Part III line 7: Medicare revenue minus the cost of Medicare care. A figure in parentheses is a shortfall. Like bad debt, it is not community benefit on the IRS form.
Source: Form 990, University of Rochester, EIN 16-0743209, fiscal year ending 2025-06, as published by the IRS. CEO identification: ceo title multiple.
§2Community benefit versus charity care
The rest of line 7k is Medicaid shortfall, medical education, research, subsidized services and contributions. Bad debt ($25.5M) and Medicare shortfall are reported separately by the IRS and are not community benefit on the form.
Every number on this page was copied from the filing linked above. If a figure is wrong, send the filing that contradicts it and the correction runs at the top of this page.
§Share
